Trial intelligence / Profile preview

Sulfadoxine-pyrimethamine for malaria prevention in pregnant women in Nigeria

NCT01636895Phase 4Unknown

Sponsor
Malaria Consortium
Start
Jan 2011
Primary completion
Nov 2012
Modality
Classical Binding Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sulfadoxine, pyrimethamine in malaria, sponsored by Malaria Consortium. Status: unknown.

02

Drugs

sulfadoxinepyrimethamine
03

Conditions

malaria

Beyond the preview

Go deeper on NCT01636895.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01636895.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call